Methods and compositions concerning poxviruses and cancer

Details for Australian Patent Application No. 2003258168 (hide)

Owner Jennerex, Inc.

Inventors Kirn, David; Thorne, Steve H

Agent Pizzeys

Pub. Number AU-B-2003258168

PCT Number PCT/US03/25141

PCT Pub. Number WO2004/014314

Priority 60/402,857 12.08.02 US

Filing date 11 August 2003

Wipo publication date 25 February 2004

Acceptance publication date 29 October 2009

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61K 39/285 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 7/01 (2006.01) Viruses, e.g. bacteriophages - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

C12N 15/863 (2006.01) Mutation or genetic engineering - Poxviral vectors, e.g. vaccinia virus

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

Event Publications

13 November 2003 Complete Application Filed

  Priority application(s): 60/402,857 12.08.02 US

8 April 2004 Application Open to Public Inspection

  Published as AU-B-2003258168

23 November 2006 Amendment Made

  The nature of the amendment is: Add coinventor Thorne, Steve H 2004

30 November 2006 Assignment before Grant

  Kirn, David The application has been assigned to Jennerex Biotherapeutics LLC

14 December 2006 Corrigenda

  Assignments Before Grant, Section 113 - 2003 Unader the name Jennerex Biotherapeutics LLC, Application No. 2003258168, Under INID(71), correct to read Jennerex Biotherapeutics ULC

27 November 2008 Alteration of Name

  The name of the applicant has been altered to Jennerex, Inc.

29 October 2009 Application Accepted

  Published as AU-B-2003258168

25 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003258169-PHARMACOLOGICAL TREATMENT OF PSORIASIS

2003258167-DRUG DELIVERY PARTICLE